+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Comorbidities in patients with psoriatic arthritis: a comparison with rheumatoid arthritis and psoriasis



Comorbidities in patients with psoriatic arthritis: a comparison with rheumatoid arthritis and psoriasis



International Journal of Rheumatic Diseases 18(8): 873-879



Psoriatic arthritis (PsA) is a chronic, inflammatory disease. The purpose of this study was to examine the association between PsA and comorbid conditions. This is the first study to investigate comorbid diseases in PsA in Turkey. This study was performed under the auspices of the Anatolian Group for the Assessment in Rheumatic Diseases (ANGARD) and involved participation by six university research hospitals. Patients diagnosed with and treated for PsA on the basis of clinical, radiological and laboratory findings and expert opinion were monitored using standardized examination methods and jointly prepared forms. Clinical status, accompanying systemic diseases and surgical history were recorded. One hundred and seventy-three patients with PsA (75 male, 98 female, mean age 41.8) and 138 patients with rheumatoid arthritis (RA) (17 male, 121 female, mean age 48.6) and 67 with psoriasis (PsO) (43 male, 24 female, mean age 36.1) were included in the study. No accompanying disease was determined in 72.8% of PsA, 50.0% of RA and 80.6% of PsO groups. In regression analysis, patients with PsA had higher risk for cataract/glaucoma surgery (odds ratio [OR] = 11.99; 95% CI 1.36-105.4, P = 0.025) compared to patients with RA, and higher risk for hypertension (HT) (OR = 4.26; 95% CI 1.27-14.23, P = 0.018) compared to the patients with PsO. Patients with PsA have relatively lower frequency of comorbidities like diabetes mellitus, HT and cataract/glaucoma surgery compared to the patients with RA. The increased risk for having cataract/glaucoma surgery in RA compared to PsA may be particularly attributed to the more prevalent glucocorticoid use in RA.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 057453902

Download citation: RISBibTeXText

PMID: 26173043

DOI: 10.1111/1756-185x.12580


Related references

AB1073Prevalence of Comorbidities in Early Stages of Inflammatory Arthritis: A Comparison of Two Cohorts of Patients with Rheumatoid Arthritis and Psoriatic Arthritis:. Annals of the Rheumatic Diseases 73(Suppl 2): 1156.1-1156, 2014

SAT0123 Evidence-Based Recommendations for the Management of Comorbidities in Rheumatoid Arthritis, Psoriasis and Psoriatic Arthritis: A Systematic Literature Search and Expert Opinion. Annals of the Rheumatic Diseases 73(Suppl 2): 635-635, 2014

Evidence-based Recommendations for the Management of Comorbidities in Rheumatoid Arthritis, Psoriasis, and Psoriatic Arthritis: Expert Opinion of the Canadian Dermatology-Rheumatology Comorbidity Initiative. Journal of Rheumatology 42(10): 1767-1780, 2015

Enhanced liver fibrosis test in patients with psoriasis, psoriatic arthritis and rheumatoid arthritis: a cross-sectional comparison with procollagen-3 N-terminal peptide (P3NP). British Journal of Dermatology 176(6): 1599-1606, 2017

Cardiovascular and other comorbidities in patients with psoriatic arthritis: a comparison with patients with psoriasis. Arthritis Care and Research 63(12): 1729-1735, 2011

Adalimumab: long-term safety in 23 458 patients from global clinical trials in rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, psoriatic arthritis, psoriasis and Crohn's disease. Annals of the Rheumatic Diseases 72(4): 517-524, 2013

SAT0130Long-term safety of adalimumab in patients from global clinical trials in rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, psoriatic arthritis, psoriasis, and crohns disease:. Annals of the Rheumatic Diseases 71(Suppl 3): 514.3-515, 2013

AB0574Prevalence of hla-drb1 in psoriatic arthritis, psoriasis and rheumatoid arthritis: comparison with healthy controls. Annals of the Rheumatic Diseases 72(Suppl 3): A965.1-A965, 2013

Comparison of four validated psoriatic arthritis screening tools in diagnosing psoriatic arthritis in patients with psoriasis (COMPAQ Study). British Journal of Dermatology 176(3): 765-770, 2017

Comparison of health-related quality of life in rheumatoid arthritis, psoriatic arthritis and psoriasis and effects of etanercept treatment. Annals of the Rheumatic Diseases 71(7): 1143-1150, 2012

Risk of diabetes among patients with rheumatoid arthritis, psoriatic arthritis and psoriasis. Annals of the Rheumatic Diseases 69(12): 2114-2117, 2010

Risk of mortality in patients with psoriatic arthritis, rheumatoid arthritis and psoriasis: a longitudinal cohort study. Annals of the Rheumatic Diseases 73(1): 149-153, 2014

Incidence and Prevalence of Cardiovascular Risk Factors Among Patients With Rheumatoid Arthritis, Psoriasis, or Psoriatic Arthritis. Arthritis Care and Research 69(10): 1510-1518, 2017

Cardiovascular risk factors predicting cardiac events are different in patients with rheumatoid arthritis, psoriatic arthritis, and psoriasis. Seminars in Arthritis and Rheumatism 48(3): 367-373, 2018

THU0606Incidence and Prevalence of Cardiovascular Risk Factors among Patients with Rheumatoid Arthritis, Psoriasis, or Psoriatic Arthritis: Table 1. Annals of the Rheumatic Diseases 75(Suppl 2): 411.2-411, 2016